Merit Medical Systems Insiders Sold US$556k Of Shares Suggesting Hesitancy
Merit Medical Systems Insiders Sold US$556k Of Shares Suggesting Hesitancy
Merit Medical Systems, Inc. (NASDAQ:MMSI) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When evaluating insider transactions, knowing whether insiders are buying is usually more beneficial than knowing whether they are selling, as the latter can be open to many interpretations. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.
Merit Medical Systems, Inc. (納斯達克:MMSI) 的股東可能會感到擔憂,因爲過去一年有多位內部人士出售了他們的股票。在評估內部交易時,了解內部人士是否在買入通常比了解他們是否在賣出更有益,因爲後者可能有多種解讀。然而,當多位內部人士在特定時間段內賣出股票時,股東應該注意,因爲這可能是一個警示信號。
Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether.
儘管我們認爲股東不應該只是跟隨內部交易,但忽視內部交易完全是愚蠢的。
The Last 12 Months Of Insider Transactions At Merit Medical Systems
Merit Medical Systems 最近12個月的內部交易
In the last twelve months, the biggest single sale by an insider was when the CFO & Treasurer, Raul Parra, sold US$479k worth of shares at a price of US$74.52 per share. That means that an insider was selling shares at slightly below the current price (US$98.22). We generally consider it a negative if insiders have been selling, especially if they did so below the current price, because it implies that they considered a lower price to be reasonable. However, while insider selling is sometimes discouraging, it's only a weak signal. It is worth noting that this sale was only 46% of Raul Parra's holding.
在過去的12個月中,內部人士最大的一次單筆出售是財務長兼財務主管Raul Parra以每股74.52美元的價格售出了價值47.9萬美元的股票。這意味着,內部人士在當前價格(98.22美元)略低的情況下出售了股票。我們通常認爲,內部人士出售股票是一種負面信號,特別是如果他們是在當前價格之下出售的,因爲這表明他們認爲該價格是合理的。然而,儘管內部人士賣出有時會令人沮喪,但這只是一個微弱的信號。值得注意的是,這次出售僅佔Raul Parra持股的46%。
Merit Medical Systems insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
Merit Medical Systems的內部人士在過去一年沒有購買任何股票。下面的圖表顯示了過去一年的內部交易(由公司和個人進行)。如果您點擊圖表,您可以看到所有個別交易,包括股價、個人和日期!
If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).
如果你喜歡買入內部人士正在買入而不是賣出的股票,那麼你可能會喜歡這份免費的公司名單。(提示:他們中的大多數正處於雷達之外)。
Insider Ownership Of Merit Medical Systems
Merit Medical Systems 的內部持股情況
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Merit Medical Systems insiders own about US$133m worth of shares (which is 2.3% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
我喜歡查看公司內部人士持有多少股份,以幫助我了解他們與內部人士的關係通常如何。 通常,內部持股越高,內部人士越可能受到激勵,以長期發展公司。 Merit Medical Systems 的內部人士持有約13300萬美元的股份(佔公司總值的2.3%)。 大多數股東會很高興看到這種內部持股,因爲這表明管理層激勵與其他股東充分對齊。
What Might The Insider Transactions At Merit Medical Systems Tell Us?
Merit Medical Systems 的內部交易可能告訴我們什麼?
There haven't been any insider transactions in the last three months -- that doesn't mean much. It's great to see high levels of insider ownership, but looking back over the last year, we don't gain confidence from the Merit Medical Systems insiders selling. Of course, the future is what matters most. So if you are interested in Merit Medical Systems, you should check out this free report on analyst forecasts for the company.
在過去三個月內沒有發生任何內部交易——這並沒有太多意義。 高水平的內部持股令人欣慰,但回顧過去一年,Merit Medical Systems 的內部人士出售股份並未讓我們獲得信心。當然,未來最重要。因此,如果您對Merit Medical Systems感興趣,您應該查看這份關於公司分析師預測的免費報告。
But note: Merit Medical Systems may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
但請注意:Merit Medical Systems可能不是最好的買入股票。所以請查看這份免費的有趣公司名單,這些公司具有高ROE和低負債。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
在本文中,內部人士是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。
譯文內容由第三人軟體翻譯。